Edwards Lifesciences Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
391,700.00
811,100.00
494,900.00
569,500.00
583,600.00
722,200
Depreciation, Depletion & Amortization
68,700.00
68,600.00
65,800.00
71,200.00
81,900.00
77,400
Other Funds
76,700.00
47,300.00
32,400.00
68,400.00
-
197,100
Funds from Operations
451,200.00
832,000.00
485,300.00
638,300.00
766,500.00
969,400
Changes in Working Capital
21,500.00
190,300.00
64,400.00
66,100.00
234,200.00
42,600
Net Operating Cash Flow
472,700.00
1,022,300.00
549,700.00
704,400.00
1,000,700.00
926,800
Capital Expenditures
110,100.00
82,900.00
106,500.00
217,400.00
175,500.00
Sale of Fixed Assets & Businesses
2,300.00
3,100.00
-
-
-
Purchase/Sale of Investments
300,900.00
527,400.00
119,600.00
4,500.00
235,700.00
Net Investing Cash Flow
412,700.00
633,000.00
316,100.00
211,700.00
647,200.00
Issuance/Reduction of Debt, Net
409,600.00
12,700.00
1,900.00
222,100.00
176,300.00
Net Financing Cash Flow
34,900.00
153,000.00
158,600.00
268,500.00
473,200.00
Net Change in Cash
109,500.00
233,400.00
64,600.00
211,700.00
111,800.00
Free Cash Flow
363,700.00
939,400.00
447,000.00
528,300.00
832,600.00
Deferred Taxes & Investment Tax Credit
100.00
71,100.00
95,000.00
37,400.00
17,800.00
27,300
Net Assets from Acquisitions
-
15,000.00
331,600.00
-
192,900.00
Other Sources
-
-
2,400.00
2,400.00
800.00
Change in Capital Stock
451,400.00
187,600.00
192,900.00
559,000.00
649,500.00
Exchange Rate Effect
14,600.00
2,900.00
10,400.00
12,500.00
7,900.00
Other Uses
4,000.00
10,800.00
-
1,200.00
43,900.00
About Edwards Lifesciences
View Profile
